NCT00109824
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,977 public trials
2,028 recruiting studies
Immunoproliferative Disorders trial results
NCT00017472
- Conditions
- Chronic Disease, Disease Attributes, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, +34 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
- Conditions
- Adnexal Diseases, Brain Diseases, Brain Neoplasms, +58 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
NCT00002556
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Eastern Cooperative Oncology Group Boston, Massachusetts, United States
NCT00262743
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT00112983
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
NCT00659568
- Conditions
- Adenocarcinoma, Blood Protein Disorders, Breast Cancer, +84 more
- Locations
-
- London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada
NCT00045006
- Conditions
- Adenocarcinoma, Adnexal Diseases, Blood Protein Disorders, +110 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00059995
- Conditions
- Dendritic Cell Sarcoma, Interdigitating, Disease Attributes, Hemic and Lymphatic Diseases, +19 more
- Locations
-
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States
Completed
Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00138164
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
- Locations
-
- Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States